Literature DB >> 20449718

Post-transplant lymphoproliferative disorder following cytomegalovirus reactivation in a lung recipient.

Akihiro Aoyama1, Mitsugu Omasa, Nobuyuki Kondo, Fengshi Chen, Hiroshi Date, Toru Bando.   

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication after lung transplantation, for which several risk factors including pretransplant seronegativity for Epstein-Barr virus are known. However, the impact of cytomegalovirus on PTLD remains to be determined. Here, we describe a case of Epstein-Barr virus-associated polymorphic PTLD that developed shortly after treatment for cytomegalovirus reactivation in a lung transplant recipient who was preoperatively seropositive for both cytomegalovirus and Epstein-Barr virus.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20449718     DOI： 10.1007/s11748-009-0526-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  15 in total

Review 1.  Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

Authors:  C V Paya; J J Fung; M A Nalesnik; E Kieff; M Green; G Gores; T M Habermann; P H Wiesner; J L Swinnen; E S Woodle; J S Bromberg
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

2.  The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation.

Authors:  A D Gascoigne; B K Shenton; M D White; I W Colquhoun; J H Dark; P A Corris
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

3.  A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.

Authors:  S M Levine; L Angel; A Anzueto; I Susanto; J I Peters; E Y Sako; C L Bryan
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

4.  Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder.

Authors:  Amitabh Gautam; Paul E Morrissey; Andrew S Brem; Staci A Fischer; Reginald Y Gohh; Angelito F Yango; Anthony P Monaco
Journal:  Pediatr Transplant       Date:  2006-08

Review 5.  Impact of cytomegalovirus infection on organ transplant recipients.

Authors:  R H Rubin
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

6.  Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.

Authors:  R Mañez; M C Breinig; P Linden; J Wilson; J Torre-Cisneros; S Kusne; S Dummer; M Ho
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

Review 7.  Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.

Authors:  Rishi Raj; Adaani E Frost
Journal:  J Heart Lung Transplant       Date:  2005-06       Impact factor: 10.247

8.  [Viral infection after lung transplantation].

Authors:  Fengshi Chen; A Aoyama; T Okamoto; A Takahashi; N Satoda; T Fujinaga; T Shoji; H Sakai; I Matsumoto; H Wada; T Bando
Journal:  Kyobu Geka       Date:  2007-10

9.  Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.

Authors:  Shao-Zhou Gao; Sandra V Chaparro; Mark Perlroth; Jose G Montoya; Joan L Miller; Sue DiMiceli; Trevor Hastie; Phillip E Oyer; John Schroeder
Journal:  J Heart Lung Transplant       Date:  2003-05       Impact factor: 10.247

10.  Pulmonary nodules in lung transplant recipients: etiology and outcome.

Authors:  Pyng Lee; Omar A Minai; Atul C Mehta; Malcolm M DeCamp; Sudish Murthy
Journal:  Chest       Date:  2004-01       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.